Area of research
Rheumatology · Molecular Biology
Research interest
Research focused on Anakinra and Infliximab, with related work in Adalimumab, Rheumatoid arthritis, Etanercept. Notable publications include 'Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis', 'Obesity and reduction of the response rate to anti–tumor necrosis factor α in rheumatoid arthritis: An approach to a personalized medicine', and 'Anakinra treatment in drug-resistant Behcet’s disease: a case series'.
An observational prospective study on predictors of clinical response at six months in patients with active psoriatic arthritis treated with golimumab.
PubMed 2020cited by 19position: middle
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study
Hydrostatic Pressure Regulates MicroRNA Expression Levels in Osteoarthritic Chondrocyte Cultures via the Wnt/β-Catenin Pathway
Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries.
PubMed 2017cited by 8position: middle
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study
Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey
Arrhythmogenicity of Anti-Ro/SSA Antibodies in Patients With Torsades de Pointes
Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability
Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry.
PubMed 2015cited by 109position: middle
Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection
PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists
Diagnosis and classification of relapsing polychondritis
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease
Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case Series
Biological Treatments in Behçet’s Disease: Beyond Anti-TNF Therapy
Key facts and hot spots on tumor necrosis factor receptor‐associated periodic syndrome
Drug Retention Rates and Treatment Discontinuation among Anti-TNF-<i>α</i>Agents in Psoriatic Arthritis and Ankylosing Spondylitis in Clinical Practice
The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: Results from the GISEA register
Anakinra treatment in drug-resistant Behcet’s disease: a case series
The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: Clinical manifestations and long-term follow-up
Monogenic Autoinflammatory Syndromes: State of the Art on Genetic, Clinical, and Therapeutic Issues
Biological Treatments: New Weapons in the Management of Monogenic Autoinflammatory Disorders
Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients
First Report of Circulating MicroRNAs in Tumour Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS)
High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: data from GISEA, the Italian biologics register